Biophysical and Stability Characterization of Antibody-Drug Conjugates

What does the future of your drug discovery program look like? Many industry leaders are finding themselves in uncharted waters: the science is more sophisticated than ever, producing paradigm-altering treatments. But, historically high R&D costs and low success rates has emphasized the need to identify drugs focused on translationally-relevant targets in the most cost and time efficient way.

Western blotting uses antibodies to identify individual proteins within a cell or tissue lysate. It is an important life sciences technique that involves many steps. When done well Western blotting delivers useful information to the researcher. Good results can, at times, be challenging. Sourcing quality reagents and finding ways to avoid repeating experiments is essential. This webinar offers insights into the tips and tricks that can help you generate better Western blot data and will discuss advances that have allowed the automation of protein separation and immunodetection of traditional Western blotting.

Learn more on burn injury, prevention and the immediate care needed for patients with burn injuries. In the United States, approximately 486,000 people seek medical treatment for burns each year. Many people may not recognize their risk of burn injury. This material will review burn injuries, including types of burns and immediate care for burns and explore the effect of burn injuries on the pulmonary, cardiac, and renal systems. It will cover the classification system used for burn injuries describe the local and systemic effects of a major burn injury, discuss the potential fluid and electrolyte alterations of the emergent/resuscitative and acute phases of burn management, describe care of the patient with burn injuries, and identify the appropriate patient referral to a burn center.

The AVENIO Tumor Tissue Targeted Kit is a next-generation sequencing (NGS) assay for comprehensive genomic profiling of solid tumors from formalin-fixed paraffin-embedded (FFPE) tissue samples. It contains 17 guideline-aligned biomarkers, including those in the U.S. National Comprehensive Cancer Network (NCCN).